Article

Companies will co-promote line of lid scrub eye cleanser

CYNACON/OCuSOFT and Alimera Sciences Inc. will co-promote OCuSOFT lid scrub eyelid cleansers. Alimera sales representatives will provide details and samples of OCuSOFT's lid scrub family of eyelid cleansers to existing ophthalmic and optometric customers.

CYNACON/OCuSOFT and Alimera Sciences Inc. will co-promote OCuSOFT lid scrub eyelid cleansers. Alimera sales representatives will provide details and samples of OCuSOFT's lid scrub family of eyelid cleansers to existing ophthalmic and optometric customers.

"We could not be more excited about this partnership," said Cynthia L. Barratt, president and chief executive officer of CYNACON/OCuSOFT. "The entire executive staff at Alimera has prior experience managing a national campaign for another brand in the eyelid hygiene category. Collectively, we now have not only the number-one brand, but a strong, experienced management team as well."

OCuSOFT lid scrub is available in pre-moistened pads, solution, and a new lid scrub foam.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.